The Weekly Litigation News Digest is now live. Subscribe now

Liquid Pharmaceutical Composition Comprising Pemetrexed - EP3206666

The patent EP3206666 was granted to Synthon on Dec 11, 2019. The application was originally filed on Oct 9, 2015 under application number EP15778927A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3206666

SYNTHON
Application Number
EP15778927A
Filing Date
Oct 9, 2015
Status
Opposition Rejected
Feb 21, 2025
Publication Date
Dec 11, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LARSEN & BIRKEHOLMSep 2, 2020LARSEN & BIRKEHOLMADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2666463
INTERNATIONAL-SEARCH-REPORTWO2012015810
INTERNATIONAL-SEARCH-REPORTWO2013179248
OPPOSITIONCN1907284
OPPOSITIONEP2854765
OPPOSITIONEP3008064
OPPOSITIONWO0156575
OPPOSITIONWO2013178214
OPPOSITIONWO2014198338

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents